KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 112 filers reported holding KYMERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,334,176 | -17.9% | 44,696 | +10.6% | 0.00% | 0.0% |
| Q1 2024 | $1,625,005 | +66.6% | 40,423 | +5.5% | 0.00% | +100.0% |
| Q4 2023 | $975,653 | +74.8% | 38,321 | -4.6% | 0.00% | 0.0% |
| Q3 2023 | $558,141 | -38.3% | 40,154 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $904,450 | -32.7% | 39,341 | -13.3% | 0.00% | -50.0% |
| Q1 2023 | $1,344,817 | +21.4% | 45,387 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $1,107,750 | +16.0% | 44,381 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $955,000 | +9.0% | 43,862 | -1.4% | 0.00% | +100.0% |
| Q2 2022 | $876,000 | -46.7% | 44,491 | +14.7% | 0.00% | -50.0% |
| Q1 2022 | $1,642,000 | -38.9% | 38,801 | -8.4% | 0.00% | -33.3% |
| Q4 2021 | $2,689,000 | +11.8% | 42,354 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $2,406,000 | +24.5% | 40,964 | +2.8% | 0.00% | +50.0% |
| Q2 2021 | $1,933,000 | +227.1% | 39,855 | +162.1% | 0.00% | +100.0% |
| Q1 2021 | $591,000 | -37.5% | 15,204 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $946,000 | – | 15,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |